Category: Alzheimer’s Disease

June 8, 2021

Modelling the Value of Innovative Treatments For Alzheimer’s Disease in the United States

Alliance for Aging Research President and CEO Sue Peschin joined Dana Goldman, Charles Makin, and…
June 7, 2021

Alliance for Aging Research’s Statement on FDA Decision to Approve Alzheimer’s Treatment

Alliance for Aging Research President and CEO Sue Peschin, MHS, released the following statement in response to the FDA’s decision…
June 3, 2021

Blog: A Better Framework to Assess the Value of Alzheimer’s Treatments

Bruce Pyenson, FSA, MAAAPrincipal, Consulting Actuary at Milliman  The Alliance for Aging Research recently released a report, “Assessing…
May 12, 2021

New Report Describes Better Framework for Assessing Value of Alzheimer’s Treatments

Today the Alliance for Aging Research released a report, “Assessing the Value of Therapies in Alzheimer’s Disease: Considerations…
April 26, 2021

Alliance for Aging Research Releases New Educational Films on Neuropsychiatric Symptoms

Diseases and injuries that damage the brain can impact how we interact with the world and lead to significant and…
April 22, 2021

New Analysis Shows International Reference Drug Pricing Would Have a Catastrophic Impact on Alzheimer’s Disease Research

The number of Americans aged 65 and older with Alzheimer´s disease (AD) is expected to more than double from 6.2…
March 4, 2021

ACT-AD Sponsor Spotlight: Avanir’s Sanjay Dubé, M.D.

Check out this ACT-AD sponsor highlight of Avanir Pharmaceuticals, featuring Sanjay Dubé, M.D., the Head of Clinical Development and Scientific…
August 11, 2020

Blog: Get to Know Jim and Geri Taylor, Recipients of the 2020 Perennial Hero Award

Jim and Geri Taylor, recipients of the 2020 Perennial Hero Award. Heroes in Health: An Event to Celebrate…
June 29, 2020

Blog: Alzheimer’s Disease and the COVID-19 Pandemic

Ian Kremer, Executive Director of the LEAD Coalition By Ian Kremer Executive Director, Leaders Engaged on Alzheimer’s Disease…
March 16, 2020

Alliance for Aging Research Responds to Senate Finance Subcommittee on Health Care RFI on Alzheimer’s Disease

The Senate Finance Subcommittee on Health Care held a hearing in November 2019 on the barriers to the diagnosis,…